Treatment of multidrug-resistant Acinetobacter species infection often requires the use of drugs with which there is limited clinical experience

Author： Adis International Limited  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.24, Iss.11, 2008-11, pp. : 10-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment Options for Multidrug-Resistant Acinetobacter Species

By Gilad Jacob  

Drugs, Vol. 68, Iss. 2, 2008-01 ,pp. : 165-189

Adis International

Access to resources Recommend Favorite

Treatment and Prevention of Multidrug-Resistant Tuberculosis

By Bastian I.   Colebunders R.  

Drugs, Vol. 58, Iss. 4, 1999-10 ,pp. : 633-661

Adis International

Access to resources Recommend Favorite

A Systematic Review of the Cost and Cost Effectiveness of Treatment for Multidrug-Resistant Tuberculosis

By Fitzpatrick Christopher   Floyd Katherine  

PharmacoEconomics, Vol. 30, Iss. 1, 2012-01 ,pp. : 63-80

Adis International

Access to resources Recommend Favorite

Linezolid was effective in the treatment of a case of multidrug-resistant tuberculotic spondylitis

By  

Inpharma, Vol. 1, Iss. 1495, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Current review of antimicrobial treatment of nosocomial pneumonia caused by multidrug-resistant pathogens

By Jean Shio-Shin   Hsueh Po-Ren  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 14, 2011-10 ,pp. : 2145-2148

Informa Healthcare

Access to resources Recommend Favorite